dihexa clinical studies Peptide Therapy: Brain & Memory Support dihexa clinical trials status Dihexa
Description
In conditional mouse mutants, in which the expression of the Igf1r gene was ablated exclusively in neurons and OPC of the cerebrum, there was a reduced accumulation of OPC, leading to a decreased amount of newly generated oligodendrocytes (Mason et al., 2003)
The Phase 3 REDEFINE program for CagriSema in obesity is ongoing
Someone using a GLP-1 agonist for appetite control might add 5-amino-1mq to enhance fat metabolism and preserve muscle mass
It was experimentally proven that the deheterochromatization level of facultative heterochromatin changed significantly to values higher than those of both control groups after peptide treatment
Cytoskeletal & Cell Migration Pathways The peptide influences actin cytoskeleton dynamics through the FAK (Focal Adhesion Kinase) / Paxillin signaling axis
Using the Linear Design algorithm, they developed novel designs for SARS-CoV-2 spike protein and varicella-zoster virus glycoprotein E protein
